Carré Technologies creates software and hardware solutions for capturing and recording biosignals, enabling both real‑time and offline analysis.
Funding
Funding not disclosed
Founders
Product
Problem
Collecting high-quality biosignals often requires specialized hardware and complex software pipelines, which can be costly and time‑consuming for medical, research, and wearable device developers. Inadequate signal processing leads to noisy data, limited real‑time insights, and difficulty integrating analytics into existing workflows.
Solution
Carré Technologies offers an integrated suite of hardware devices and software tools that capture, compress, and enhance biosignals for both real‑time and offline analysis. Their platform provides a library of standard algorithms for signal quality improvement, compression, and database mining, as well as the ability to develop custom processing pipelines tailored to specific applications. By delivering modular, API‑driven components, Carré enables customers to embed advanced biosignal analytics directly into medical devices, research platforms, or wearable products, accelerating development cycles and improving data reliability.
Target Audience
Primary customers are medical device manufacturers, biomedical research labs, and wearable technology companies that require reliable biosignal acquisition and advanced analytics.
Features
- Modular hardware sensors optimized for a range of biosignals (e.g., ECG, EMG, EEG) with built-in data acquisition and streaming capabilities
- Standard algorithm library for signal compression, noise reduction, and quality assessment
- Customizable algorithm development environment supporting real‑time processing and offline database mining
- API and SDK integrations for seamless embedding of analytics into existing software stacks and device firmware
- Cloud‑compatible data export formats enabling secure storage and large‑scale analysis